Efficacy and safety of sonothrombolysis for acute ischemic stroke: a multi-centre, double-blind, phase 3, randomised controlled trial

Alexandrov, A. V. et al. (2018) Efficacy and safety of sonothrombolysis for acute ischemic stroke: a multi-centre, double-blind, phase 3, randomised controlled trial. Lancet Neurology, (Accepted for Publication)

Alexandrov, A. V. et al. (2018) Efficacy and safety of sonothrombolysis for acute ischemic stroke: a multi-centre, double-blind, phase 3, randomised controlled trial. Lancet Neurology, (Accepted for Publication)

[img] Text
176082.pdf - Accepted Version
Restricted to Repository staff only

690kB

Abstract

No abstract available.

Item Type:Articles
Additional Information:This study was supported by Cerevast Therapeutics, Inc (Redmond, WA)
Status:Accepted for Publication
Refereed:Yes
Glasgow Author(s) Enlighten ID:Muir, Professor Keith
Authors: Alexandrov, A. V., Köhrmann, M., Soinne, L., Tsivgoulis, G., Barreto, A. D., Demchuk, A. M., Sharman, V. K., Mikulik, R., Muir, K., Brandt, G., Alleman, J., Grotta, J. C., Levi, C. R., Molina, C. A., Saqqur, M., Mavridis, D., Psaltopoulou, T., Vosko, M., Fiebach, J. B., Mandava, P., Kent, T. A., Alexandrov, A. W., and Schellinger, P. D.
College/School:College of Medical Veterinary and Life Sciences > Institute of Neuroscience and Psychology
Journal Name:Lancet Neurology
Publisher:The Lancet Publishing Group
ISSN:1474-4422
ISSN (Online):1474-4465

University Staff: Request a correction | Enlighten Editors: Update this record